These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Pharmacotherapy of hepatitis B infection: a brief review. Quan DJ Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082 [TBL] [Abstract][Full Text] [Related]
49. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon? Kao JH Liver Int; 2014 Feb; 34 Suppl 1():112-9. PubMed ID: 24373087 [TBL] [Abstract][Full Text] [Related]
50. Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon. Marcellin P; Sung J; Piratvisuth T Liver Int; 2010 May; 30(5):657-68. PubMed ID: 20158610 [TBL] [Abstract][Full Text] [Related]
51. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective. Chien RN J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437 [TBL] [Abstract][Full Text] [Related]
52. [Management of chronic hepatitis B in treatment-naive patients]. Cheong JY Korean J Gastroenterol; 2008 Jun; 51(6):338-45. PubMed ID: 18604135 [TBL] [Abstract][Full Text] [Related]
53. [New approaches in the treatment of hepatitis B]. Sagir A; Avci A; Erhardt A; Lörke J; Heintges T; Häussinger D Dtsch Med Wochenschr; 2004 May; 129(21):1203-8. PubMed ID: 15160325 [No Abstract] [Full Text] [Related]
54. [Pharmacological treatment of acute hepatitis B]. García-Alonso FJ; Martín-Mateos RM; Moreira Vicente V Med Clin (Barc); 2012 May; 138(14):633-7. PubMed ID: 22118973 [TBL] [Abstract][Full Text] [Related]
55. Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon. Ghany MG Best Pract Res Clin Gastroenterol; 2017 Jun; 31(3):299-309. PubMed ID: 28774412 [TBL] [Abstract][Full Text] [Related]
56. Current practice of chronic hepatitis B treatment in Southern Italy. Stroffolini T; Spadaro A; Di Marco V; Scifo G; Russello M; Montalto G; Bertino G; Surace L; Caroleo B; Foti G; Portelli V; Madonia S; Sapienza M; Cosco L; Frugiuele P; Galdieri A; Brandolino N; Siciliano R; Bruno S; Almasio PL; Eur J Intern Med; 2012 Jul; 23(5):e124-7. PubMed ID: 22726382 [TBL] [Abstract][Full Text] [Related]
57. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues. Buster EH; Schalm SW; Janssen HL Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869 [TBL] [Abstract][Full Text] [Related]
58. [Pharmacological agents for the treatment of chronic hepatitis B]. Sánchez-Tapias JM Gastroenterol Hepatol; 2008 Mar; 31(3):120-8. PubMed ID: 18341843 [No Abstract] [Full Text] [Related]
59. Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients? Viganò M; Invernizzi F; Lampertico P Liver Int; 2015 Jan; 35 Suppl 1():107-13. PubMed ID: 25529095 [TBL] [Abstract][Full Text] [Related]
60. HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs? Buti M Liver Int; 2014 Feb; 34 Suppl 1():108-11. PubMed ID: 24373086 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]